DOCSLIB.ORG

Short and Long-Term Outcomes of the Manchester Procedure for Pelvic Organ Prolapse and the Impact of Major Levator Ani Muscle Defects

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Short and Long-Term Outcomes of the Manchester Procedure for Pelvic Organ Prolapse and the Impact of Major Levator Ani Muscle Defects Short and long-term outcomes of the Manchester Procedure for Pelvic Organ Prolapse and the impact of major Levator Ani Muscle defects PhD thesis by Sissel Hegdahl Oversand, MD 2018 Department of Gynaecology, Oslo University Hospital, Ullevål and University of Oslo, Faculty of Medicine, Norway © Sissel Hegdahl Oversand, 2018 Series of dissertations submitted to the Faculty of Medicine, University of Oslo ISBN 978-82-8377-335-4 All rights reserved. No part of this publication may be reproduced or transmitted, in any form or by any means, without permission. Cover: Hanne Baadsgaard Utigard. Print production: Reprosentralen, University of Oslo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`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≥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
Load more

Recommended publications
  • Obliterative Lefort Colpocleisis in a Large Group of Elderly Women
    Obliterative LeFort Colpocleisis in a Large Group of Elderly Women Salomon Zebede, MD, Aimee L. Smith, MD, Leon N. Plowright, MD, Aparna Hegde, MD, Vivian C. Aguilar, MD, and G. Willy Davila, MD OBJECTIVE: To report on anatomical and functional satisfaction. Associated morbidity and mortality related outcomes, patient satisfaction, and associated morbidity to the procedure are low. Colpocleisis remains an and mortality in patients undergoing LeFort colpocleisis. excellent surgical option for the elderly patient with METHODS: This was a retrospective case series of advanced pelvic organ prolapse. LeFort colpocleisis performed from January 2000 to (Obstet Gynecol 2013;121:279–84) October 2011. Data obtained from a urogynecologic DOI: http://10.1097/AOG.0b013e31827d8fdb database included demographics, comorbidities, medi- LEVEL OF EVIDENCE: III cations, and urinary and bowel symptoms. Prolapse was quantified using the pelvic organ prolapse quantification y 2050, the elderly will represent the largest section (POP-Q) examination. Operative characteristics were Bof the population and pelvic floor dysfunction is recorded. All patients underwent pelvic examination projected to affect 58.2 million women in the United and POP-Q assessment at follow-up visits. Patients also States. We thus can expect to see a increase in the were asked about urinary and bowel symptoms as well as demand for urogynecologic services in this popula- overall satisfaction. All intraoperative and postoperative tion.1,2 Most women older than age 65 years are surgical complications were recorded. afflicted with at least one chronic medical condition, RESULTS: Three hundred twenty-five patients under- and, with the rate of comorbid conditions increasing went LeFort colpocleisis.
    [Show full text]
  • Curriculum Vitae
    CURRICULUM VITAE G. WILLY DAVILA, M.D. GUILLERMO H. DAVILA, M.D., FACOG, FPMRS Medical Director, Women and Children’s Services Holy Cross Medical Group Center for Urogynecology and Pelvic Floor Medicine Dorothy Mangurian Comprehensive Women’s Center Holy Cross Health Fort Lauderdale, Florida, USA Academic positions: Affiliate Professor, Florida Atlantic University School of Medicine Clinical Associate Professor, University of South Florida, Dept. of Obstetrics and Gynecology Address: Holy Cross HealthPlex Dorothy Mangurian Comprehensive Women’s Center 1000 NE 56th Street Fort Lauderdale, Florida 33334 Phone (954) 229-8660 FAX (954) 229-8659 Email: [email protected] Education 1976-1979 University of Texas at El Paso, Texas B.S. Biology 1976-1977 University of Bolivia Medical School, La Paz, Bolivia no degree 1979-1983 University of Texas Medical School, Houston, Texas M.D. Residency 1983-1987 University of Colorado Health Sciences Center, Denver, Colorado Obstetrics and Gynecology Postgraduate Training 1989 Gynecological Urology Clinical Preceptorship: Long Beach Memorial Hospital, University of California, Irvine Donald Ostergard, M.D., Director Previous Positions: 1999-2017 Chairman, Department of Gynecology, Cleveland Clinic Florida 1999-2018 Head, Section of Urogynecology and Reconstructive Pelvic Surgery Cleveland Clinic Florida Director, The Pelvic Floor Center at Cleveland Clinic Florida A National Association for Continence (NAFC) Center of Excellence in Pelvic Floor Care Director, Clinical Fellowship program - Urogynecology and Reconstructive Pelvic Surgery (2000-2007) 2015-2016 Clinical Director, Global Patient Services (Weston) Cleveland Clinic Foundation, International Center 2013-2016 Center Director, Obstetrics and Gynecology and Women’s Health Institute (Weston) Cleveland Clinic Foundation 1992-1999 Director, Colorado Gynecology and Continence Center, P.C.
    [Show full text]
  • Colpocleisis (Closing the Vagina to Treat Prolapse)
    Colpocleisis (Closing the vagina to treat prolapse) Patient Information Leaflet About this leaflet The information provided in this leaflet should be used as a guide. There may be some variation in how each gynaecologist performs the procedure, the care procedures on the ward immediately after your operation and the advice given to you when you get home. You should ask your gynaecologist about any concerns that you may have. You should take your time to read this leaflet. A page is provided at the end of the leaflet for you to write down any questions you may have. It is your right to know about your planned operation/procedure, why it has been recommended, what the alternatives are and what the risks and benefits are. These should be covered in this leaflet. You may also wish to ask about your gynaecologist’s personal experience and results of treating your condition. Benefits and risks The success and the risks of most operations carried out to treat prolapse and incontinence have been poorly studied and so it is often not possible to define them clearly. In this leaflet risks may be referred to as common, rare etc. or an approximate level of risk may be given. Further information about risk is explained in a leaflet published by the Royal College of Obstetricians and Gynaecologists “Understanding how risk is discussed in healthcare”. https://www.rcog.org.uk/globalassets/documents/patients/patient-information-leaflets/pi- understanding-risk.pdf The following table is taken from that leaflet British Society of Urogynaecology (BSUG) database In order to better understand the success and risks of surgery for prolapse and incontinence the British Society of Urogynaecology has established a national database.
    [Show full text]
  • Sl.No CGHS Treatment Procedure/Investigation List Rates for Non NABH Rates for NABH CGHS Bengaluru Rate List
    CGHS Bengaluru Rate List Sl.No CGHS Treatment Procedure/Investigation Rates for Non Rates for List NABH NABH 1 Consultation OPD 135 135 2 Consultation- for Inpatients 270 270 3 Dressings of wounds 45 52 4 Suturing of wounds with local anesthesia 108 124 5 Aspiration Plural Effusion - Diagnostic 120 138 6 Aspiration Plural Effusion - Therapeutic 174 200 7 Abdominal Aspiration - Diagnostic 330 380 8 Abdominal Aspiration - Therapeutic 414 476 9 Pericardial Aspiration 342 393 10 Joints Aspiration 285 329 11 Biopsy Skin 207 239 12 Removal of Stitches 36 41 13 Venesection 124 143 14 Phimosis Under LA 1180 1357 15 Sternal puncture 173 199 16 Injection for Haemorrhoids 373 428 17 Injection for Varicose Veins 315 363 18 Catheterisation 425 500 19 Dilatation of Urethra 450 518 20 Incision & Drainage 378 435 21 Intercostal Drainage 125 144 22 Peritoneal Dialysis 1319 1517 TREATMENT PROCEDURE SKIN 23 Excision of Moles 311 357 24 Excision of Warts 279 321 25 Excision of Molluscum contagiosum 117 135 26 Excision of Veneral Warts 144 166 27 Excision of Corns 126 145 28 I/D Injection Keloid 97 112 29 Chemical Cautery (s) 99 114 TREATMENT PROCEDURE OPTHALMOLOGY 30 66 76 eyes Subconjunctival/subtenon’s injections in one 31 132 152 eyes 32 PterygiumSubconjunctival/subtenon’s Surgery injections in both 5550 6325 33 Conjunctival Peritomy 58 67 34 Conjunctival wound repair or exploration 3300 3795 following blunt trauma 35 Removal of corneal foreign body 115 132 36 Cauterization of ulcer/subconjunctival injection 69 79 in one eye 37 Cauterization of ulcer/subconjunctival
    [Show full text]
  • General User Charges in AIIMS Raipur
    General User Charges in AIIMS Raipur S No. Name of General Charges Paying Ward General Remark Ward/OPD 1 Registration Charges 200 25 2 Bed Charges Per Day (Sami 2000 35 Patients being adm Deluxe) itted in 3 Bed Charges Per Day (Deluxe) 3000 35 Paying/General 4 Diet Charges Per Day 200 Optional Nil ward will pay an advance for 10 days charges at the time of admission. 5 ICU/NICU/PICU/CCU Charges 1000 (Above & 300 Per Day Over to Bed Charge 6 Minor Operation in OT/MOT 250 100 not mentioned in list, under L A 7 Minor Operation in OT/MOT 1000 300 not mentioned in list, under G A 8 Major Operation in OT, Not 2000 1000 mentioned in list under G A 9 Medical Certificate (Sickness) 10 10 10 Medical Certificate (Fitness) 10 10 11 Tubectomy / Laparoscopic 25 20 Sterilization 12 Death file charges 25 25 13 Medico Legal Injury Report 50 50 (MLR) 14 Birth / Death Certificate 1st 0 0 Copy 15 Birth / Death Certificate 5 5 Subsequent Copy 16 Additional correction in Birth 10 10 / Death / certificate 17 Completion of LIC / Insurance 50 50 claim file 18 Subsequent Pass if on special 50 50 condition 19 Supply of blood (One Unit) 250 75 1 20 Medical Board Certificate 500 500 On Special Case User Charges for Investigations in AIIMS Raipur S No. Name of Investigations Paying General Remark Ward Ward/OPD Anaesthsia 1 ABG 75 50 2 ABG ALONGWITH 150 100 ELECTROLYTES(NA+,K+)(Na,K) 3 ONLY ELECTROLYTES(Na+,K+,Cl,Ca+) 75 50 4 ONLY CALCIUM 50 25 5 GLUCOSE 25 20 6 LACTATE 25 20 7 UREA.
    [Show full text]
  • Overview of Surgical Techniques in Gender-Affirming Genital Surgery
    208 Review Article Overview of surgical techniques in gender-affirming genital surgery Mang L. Chen1, Polina Reyblat2, Melissa M. Poh2, Amanda C. Chi2 1GU Recon, Los Angeles, CA, USA; 2Southern California Permanente Medical Group, Los Angeles, CA, USA Contributions: (I) Conception and design: ML Chen, AC Chi; (II) Administrative support: None; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: None; (V) Data analysis and interpretation: None; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Amanda C. Chi. 6041 Cadillac Ave, Los Angeles, CA 90034, USA. Email: [email protected]. Abstract: Gender related genitourinary surgeries are vitally important in the management of gender dysphoria. Vaginoplasty, metoidioplasty, phalloplasty and their associated surgeries help patients achieve their main goal of aligning their body and mind. These surgeries warrant careful adherence to reconstructive surgical principles as many patients can require corrective surgeries from complications that arise. Peri- operative assessment, the surgical techniques employed for vaginoplasty, phalloplasty, metoidioplasty, and their associated procedures are described. The general reconstructive principles for managing complications including urethroplasty to correct urethral bulging, vaginl stenosis, clitoroplasty and labiaplasty after primary vaginoplasty, and urethroplasty for strictures and fistulas, neophallus and neoscrotal reconstruction after phalloplasty are outlined as well. Keywords: Transgender; vaginoplasty; phalloplasty; metoidioplasty Submitted May 30, 2019. Accepted for publication Jun 20, 2019. doi: 10.21037/tau.2019.06.19 View this article at: http://dx.doi.org/10.21037/tau.2019.06.19 Introduction the rectum and the lower urinary tract, formation of perineogenital complex for patients who desire a functional The rise in social awareness of gender dysphoria has led vaginal canal, labiaplasty, and clitoroplasty.
    [Show full text]
  • Shirodkar's Extended Manchester Repair
    International Journal of Recent Trends in Science And Technology, ISSN 2277-2812 E-ISSN 2249-8109, Volume 10, Issue 2, 2014 pp 263-266 Shirodkar’s Extended Manchester Repair: A Conservative Vaginal Surgery for Genital Prolapse in Young Women and Reinforcement of Weak Uterosacral Ligaments with Merselene Tape: Retrospective and Prospective Study Roohi Shaikh 1, Suman Sardesai 2* 1Assistant Professor, Department of OBGY, Indian Institute of Medical Science and Research, Warudi, Badnapur, Jalna Maharashtra INDIA. 2Professor and HOD, Department of OBGY, Dr. V. M. Medical College, Solapur, INDIA. *Corresponding Address: *[email protected], #[email protected] Research Article Abstract: The aim of this study was to evaluate the results of ligaments to the anterior aspect of what remains of the Shirodkar Extended Manchester Repair operation for uterine cervix, an anterior colporrphaphy and perineorhhapy is prolapse in young women interested in retaining future done. This time honoured technique has various childbearing and menstrual function. Materials and Methods: 30 patients with II or III degree utero-vaginal prolapse with or without shortcomings i.e. cervical stenosis, infertility, cervical cystoenterorectocoele and with normal uterocervical length (i.e. no incompetence, cervical dystocia during labour, cervical elongation) in child-bearing age group (i.e. less than 35 dyspareunia and recurrence of prolapse after pregnancy or years) interested in preserving future fertility or menstrual function otherwise was also reported to the extent of 20-25% were operated and followed-up. In patients with weak uterosacral (Shaw 1933).An ideal conservative method should ligament, reinforcement with merselene tape was done. Results: In preserve menstruation, restore the fertility and should not this study, 79% of the patients were below the age of 30 years.
    [Show full text]
  • OBGYN-Study-Guide-1.Pdf
    OBSTETRICS PREGNANCY Physiology of Pregnancy: • CO input increases 30-50% (max 20-24 weeks) (mostly due to increase in stroke volume) • SVR anD arterial bp Decreases (likely due to increase in progesterone) o decrease in systolic blood pressure of 5 to 10 mm Hg and in diastolic blood pressure of 10 to 15 mm Hg that nadirs at week 24. • Increase tiDal volume 30-40% and total lung capacity decrease by 5% due to diaphragm • IncreaseD reD blooD cell mass • GI: nausea – due to elevations in estrogen, progesterone, hCG (resolve by 14-16 weeks) • Stomach – prolonged gastric emptying times and decreased GE sphincter tone à reflux • Kidneys increase in size anD ureters dilate during pregnancy à increaseD pyelonephritis • GFR increases by 50% in early pregnancy anD is maintaineD, RAAS increases = increase alDosterone, but no increaseD soDium bc GFR is also increaseD • RBC volume increases by 20-30%, plasma volume increases by 50% à decreased crit (dilutional anemia) • Labor can cause WBC to rise over 20 million • Pregnancy = hypercoagulable state (increase in fibrinogen anD factors VII-X); clotting and bleeding times do not change • Pregnancy = hyperestrogenic state • hCG double 48 hours during early pregnancy and reach peak at 10-12 weeks, decline to reach stead stage after week 15 • placenta produces hCG which maintains corpus luteum in early pregnancy • corpus luteum produces progesterone which maintains enDometrium • increaseD prolactin during pregnancy • elevation in T3 and T4, slight Decrease in TSH early on, but overall euthyroiD state • linea nigra, perineum, anD face skin (melasma) changes • increase carpal tunnel (median nerve compression) • increased caloric need 300cal/day during pregnancy and 500 during breastfeeding • shoulD gain 20-30 lb • increaseD caloric requirements: protein, iron, folate, calcium, other vitamins anD minerals Testing: In a patient with irregular menstrual cycles or unknown date of last menstruation, the last Date of intercourse shoulD be useD as the marker for repeating a urine pregnancy test.
    [Show full text]
  • UNMH Obstetrics and Gynecology Clinical Privileges Name
    UNMH Obstetrics and Gynecology Clinical Privileges Name:____________________________ Effective Dates: From __________ To ___________ All new applicants must meet the following requirements as approved by the UNMH Board of Trustees, effective April 28, 2017: Initial Privileges (initial appointment) Renewal of Privileges (reappointment) Expansion of Privileges (modification) INSTRUCTIONS: Applicant: Check off the “requested” box for each privilege requested. Applicants have the burden of producing information deemed adequate by the Hospital for a proper evaluation of current competence, current clinical activity, and other qualifications and for resolving any doubts related to qualifications for requested privileges. Department Chair: Check the appropriate box for recommendation on the last page of this form. If recommended with conditions or not recommended, provide condition or explanation. OTHER REQUIREMENTS: 1. Note that privileges granted may only be exercised at UNM Hospitals and clinics that have the appropriate equipment, license, beds, staff, and other support required to provide the services defined in this document. Site-specific services may be defined in hospital or department policy. 2. This document defines qualifications to exercise clinical privileges. The applicant must also adhere to any additional organizational, regulatory, or accreditation requirements that the organization is obligated to meet. ---------------------------------------------------------------------------------------------------------------------------------------
    [Show full text]
  • SCHEDULE of CHARGES -2018 (Eff Ective from 01.04.2018 to 31.03.2020)
    HOLY FAMILY HOSPITAL, NEW DELHI. SCHEDULE OF CHARGES -2018 (Eff ective from 01.04.2018 to 31.03.2020) HOLY FAMILY HOSPITAL HOLOKHLAY ROFAMILAD, NEWY DELHIHOSPIT - 110025AL HOLOKHLAY ROFAMILAD, NEWY DELHIHOSPIT - 110025AL OKHLA ROAD, NEW DELHI - 110025 HOLY FAMILY HOSPITAL OKHLASchedule ROAD, NEW of DELHICharges - 110025 ScheduleEffective 1of April, Charges 2018 ScheduleEffective 1of April, Charges 2018 Effective 1 April, 2018 Phone Nos: +91 11 2633 2800 to 2633 2809 Fax No : +91 11 2691 3225 +91 11 2684 5900 to 2684 5909 Email : [email protected] Phone Nos: +91 11 2633 2800 to 2633 2809 Fax No : +91 11 2691 3225 P hone Nos: Schedule +91+91 1111 Schedule 26842633 59002800 toto 26842633 of 59092809 ChargesofEmailF axCharges No : adimini: +91 11 [email protected] - 32252018 +91 11 Schedule2684 5900 to 2684 5909 ofEmail Charges : [email protected] Effective 1 April,st 2018 Eff Effectiveecti ve from 1 April, 1 April, 2018 2018 (Valid upto 31st March, 2020) Phone Nos: +91 11 2633 2800 to 2633 2809 Fax No : +91 11 2691 3225 Phone Nos: +91 11 2633 2800 to 2633 2809 Fax No : +91 11 2691 3225 +91 11 2684 5900 to 2684 5909 Email : [email protected] +91 11 2684 5900 to 2684 5909 1 Email : [email protected] HOLY FAMILY HOSPITAL, NEW DELHI. SCHEDULE OF CHARGES -2018 (Effective from 01.04.2018 to 31.03.2020) INDEX S.No. CHARGING HEAD Page No. 1 General Information 3 In-Patient Schedule of Charges 2 Room / Bed and Board 5 3 CCU/ICU / Ped. ICU / Post Op. ICU and Board 5 4 Oxygen 5 5 Ventilator 5 6 NNU – Nursery, Photo Therapy, Incubator, Nursing Care 5 7 Hospital Doctor’s Fee :- Visits 6 8 :- Consultation 6 9 Surgery Fee : General Surgery 6 10 Surgery Fee : Laparoscopic General Surgery 9 11 Surgery Fee : Hernia Surgery 12 12 Surgery Fee : Breast Surgery 12 13 Surgery Fee : Rectal Surgery 13 14 Surgery Fee : O.B.
    [Show full text]
  • ICD-9-CM Procedures (FY10)
    2 PREFACE This sixth edition of the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) is being published by the United States Government in recognition of its responsibility to promulgate this classification throughout the United States for morbidity coding. The International Classification of Diseases, 9th Revision, published by the World Health Organization (WHO) is the foundation of the ICD-9-CM and continues to be the classification employed in cause-of-death coding in the United States. The ICD-9-CM is completely comparable with the ICD-9. The WHO Collaborating Center for Classification of Diseases in North America serves as liaison between the international obligations for comparable classifications and the national health data needs of the United States. The ICD-9-CM is recommended for use in all clinical settings but is required for reporting diagnoses and diseases to all U.S. Public Health Service and the Centers for Medicare & Medicaid Services (formerly the Health Care Financing Administration) programs. Guidance in the use of this classification can be found in the section "Guidance in the Use of ICD-9-CM." ICD-9-CM extensions, interpretations, modifications, addenda, or errata other than those approved by the U.S. Public Health Service and the Centers for Medicare & Medicaid Services are not to be considered official and should not be utilized. Continuous maintenance of the ICD-9- CM is the responsibility of the Federal Government. However, because the ICD-9-CM represents the best in contemporary thinking of clinicians, nosologists, epidemiologists, and statisticians from both public and private sectors, no future modifications will be considered without extensive advice from the appropriate representatives of all major users.
    [Show full text]
  • SJH Procedures
    SJH Procedures - Gynecology and Gynecology Oncology Services New Name Old Name CPT Code Service ABLATION, LESION, CERVIX AND VULVA, USING CO2 LASER LASER VAPORIZATION CERVIX/VULVA W CO2 LASER 56501 Destruction of lesion(s), vulva; simple (eg, laser surgery, Gynecology electrosurgery, cryosurgery, chemosurgery) 56515 Destruction of lesion(s), vulva; extensive (eg, laser surgery, Gynecology electrosurgery, cryosurgery, chemosurgery) 57513 Cautery of cervix; laser ablation Gynecology BIOPSY OR EXCISION, LESION, FACE AND NECK EXCISION/BIOPSY (MASS/LESION/LIPOMA/CYST) FACE/NECK General, Gynecology, Plastics, ENT, Maxillofacial BIOPSY OR EXCISION, LESION, FACE AND NECK, 2 OR MORE EXCISE/BIOPSY (MASS/LESION/LIPOMA/CYST) MULTIPLE FACE/NECK 11102 Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); General, Gynecology, single lesion Aesthetics, Urology, Maxillofacial, ENT, Thoracic, Vascular, Cardiovascular, Plastics, Orthopedics 11103 Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); General, Gynecology, each separate/additional lesion (list separately in addition to Aesthetics, Urology, code for primary procedure) Maxillofacial, ENT, Thoracic, Vascular, Cardiovascular, Plastics, Orthopedics 11104 Punch biopsy of skin (including simple closure, when General, Gynecology, performed); single lesion Aesthetics, Urology, Maxillofacial, ENT, Thoracic, Vascular, Cardiovascular, Plastics, Orthopedics 11105 Punch biopsy of skin (including simple closure, when General, Gynecology, performed); each separate/additional lesion
    [Show full text]